Alzheimer’s disease slowly strips away memory and identity, affecting millions of people around the world. For decades, scientists have struggled to understand why it happens. Despite enormous efforts ...
A recent review by researchers at Philadelphia College of Osteopathic Medicine (PCOM) shows Chlamydia pneumoniae (Cpn) and SARS-CoV-2 infections may play a role in the pathogenesis of Alzheimer's ...
People who experience severe, hospital-treated infections face an elevated risk of developing dementia later in life, and ...
People diagnosed with HSV-1 infection had a higher risk of a subsequent Alzheimer's diagnosis. Antiherpetic drugs reduced Alzheimer's risk in those diagnosed with HSV-1. The findings apply only to ...
A common blood test marker may reveal Alzheimer’s risk years in advance. Elevated immune cells could signal danger early and ...
New research from scientists at Cleveland Clinic’s Genome Center and their collaborators at other institutions describes a pathway that human herpes simplex-1 (HSV-1) can use to contribute to the ...
A recent review by researchers at Philadelphia College of Osteopathic Medicine (PCOM) shows Chlamydia pneumoniae (Cpn) and SARS-CoV-2 infections may play a role in the pathogenesis of Alzheimer's ...
Symptomatic infection with the virus responsible for cold sores around the mouth–herpes simplex 1, or HSV-1 for short—may have a key role in the development of Alzheimer’s disease, suggests a large ...
The potentially critical role of infection in the etiology of Alzheimer's disease is largely neglected, despite decades of robust evidence from hundreds of human studies, as well as the possible ...
New research using US insurance data finds that people with HSV-1 face greater odds of Alzheimer’s disease, and suggests antiviral medications could help lower that risk. Study: Association between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results